605199 ST葫芦娃
已收盘 12-24 15:00:00
资讯
新帖
简况
异动快报:ST葫芦娃(605199)12月22日10点54分触及涨停板
中金财经 · 12-22 11:24
异动快报:ST葫芦娃(605199)12月22日10点54分触及涨停板
ST葫芦娃(605199)披露召开2025年第三次临时股东大会通知,12月15日股价下跌1.6%
证券之星 · 12-15
ST葫芦娃(605199)披露召开2025年第三次临时股东大会通知,12月15日股价下跌1.6%
ST葫芦娃(605199)披露控股股东部分股份被司法冻结,12月08日股价下跌0.45%
证券之星 · 12-08
ST葫芦娃(605199)披露控股股东部分股份被司法冻结,12月08日股价下跌0.45%
ST葫芦娃(605199)披露公司股票被实施其他风险警示相关事项的进展公告,12月01日股价下跌0.86%
证券之星 · 12-01
ST葫芦娃(605199)披露公司股票被实施其他风险警示相关事项的进展公告,12月01日股价下跌0.86%
异动快报:ST葫芦娃(605199)11月21日14点54分触及跌停板
证券之星 · 11-21
异动快报:ST葫芦娃(605199)11月21日14点54分触及跌停板
异动快报:ST葫芦娃(605199)11月5日9点49分触及涨停板
证券之星 · 11-05
异动快报:ST葫芦娃(605199)11月5日9点49分触及涨停板
每周股票复盘:ST葫芦娃(605199)股东户数降13.59%
证券之星 · 11-02
每周股票复盘:ST葫芦娃(605199)股东户数降13.59%
ST葫芦娃(605199)9月30日股东户数2.73万户,较上期减少13.59%
证券之星 · 10-31
ST葫芦娃(605199)9月30日股东户数2.73万户,较上期减少13.59%
ST葫芦娃第三季度亏损1362万元
财中社 · 10-30
ST葫芦娃第三季度亏损1362万元
ST葫芦娃最新公告:中药创新药小儿胆青双解颗粒获药物临床试验批准
证券之星 · 10-27
ST葫芦娃最新公告:中药创新药小儿胆青双解颗粒获药物临床试验批准
每周股票复盘:ST葫芦娃(605199)葫芦娃拟投1125万与关联方合作研发新药
证券之星 · 10-19
每周股票复盘:ST葫芦娃(605199)葫芦娃拟投1125万与关联方合作研发新药
ST葫芦娃(605199)披露取消监事会并修订公司章程议案获通过,10月17日股价上涨1.93%
证券之星 · 10-17
ST葫芦娃(605199)披露取消监事会并修订公司章程议案获通过,10月17日股价上涨1.93%
ST葫芦娃最新公告:拟与关联方签署技术合作开发合同
证券之星 · 10-17
ST葫芦娃最新公告:拟与关联方签署技术合作开发合同
ST葫芦娃(605199)披露选举第四届董事会职工代表董事,10月15日股价上涨0.57%
证券之星 · 10-15
ST葫芦娃(605199)披露选举第四届董事会职工代表董事,10月15日股价上涨0.57%
ST葫芦娃(605199)披露拟取消监事会并改由董事会审计委员会行使监事会职权,10月13日股价下跌1.35%
证券之星 · 10-13
ST葫芦娃(605199)披露拟取消监事会并改由董事会审计委员会行使监事会职权,10月13日股价下跌1.35%
每周股票复盘:ST葫芦娃(605199)拟取消监事会并改组董事会
证券之星 · 10-12
每周股票复盘:ST葫芦娃(605199)拟取消监事会并改组董事会
ST葫芦娃(605199)披露为全资子公司提供担保公告,9月29日股价下跌0.9%
证券之星 · 09-29
ST葫芦娃(605199)披露为全资子公司提供担保公告,9月29日股价下跌0.9%
ST葫芦娃最新公告:收到小儿肺热咳喘颗粒临床试验批准通知书
证券之星 · 09-15
ST葫芦娃最新公告:收到小儿肺热咳喘颗粒临床试验批准通知书
ST葫芦娃最新公告:公司及全资子公司获得磷酸奥司他韦干混悬剂和乳果糖口服溶液药品注册证书
证券之星 · 09-15
ST葫芦娃最新公告:公司及全资子公司获得磷酸奥司他韦干混悬剂和乳果糖口服溶液药品注册证书
ST葫芦娃:获头孢地尼胶囊药品注册证书
同花顺财经 · 09-05
ST葫芦娃:获头孢地尼胶囊药品注册证书
加载更多
公司概况
公司名称:
海南葫芦娃药业集团股份有限公司
所属行业:
医药制造业
上市日期:
2020-07-10
主营业务:
海南葫芦娃药业集团股份有限公司的主营业务是药品研发、生产、销售。公司的主要产品是小儿肺热咳喘颗粒、肠炎宁胶囊、肠炎宁颗粒、复方鲜石斛颗粒、克咳片、复方赖氨酸颗粒、复方感冒灵颗粒、养阴清肺膏、缬沙坦氨氯地平片(I)、磷酸奥司他韦胶囊、布洛芬混悬液。公司小儿肺热咳喘颗粒(每袋4克装)、肠炎宁胶囊(每粒装0.3g)、肠炎宁颗粒(每袋2g装)为独家规格产品。小儿肺热咳喘颗粒(4g)荣获西鼎会“2023-2024年度中国药品零售市场潜力品牌”、米思会“2024中国医药·品牌榜”、2024大健康产业“产品引领奖”等荣誉。公司产品肠炎宁颗粒荣获星辰会“零售药店最受欢迎的明星单品”、“2024年度中国非处方药产品综合统计排名第二名”、米思会“2024中国医药·品牌榜”、西普会“2024健康产业品牌榜”西普金奖等荣誉。复方赖氨酸颗粒荣获“2023-2024年家庭常备药儿科用药品牌”称号。
发行价格:
5.19
{"stockData":{"symbol":"605199","market":"SH","secType":"STK","nameCN":"ST葫芦娃","latestPrice":8.82,"timestamp":1766559601000,"preClose":8.95,"halted":0,"volume":4537200,"delay":0,"changeRate":-0.0145,"floatShares":400000000,"shares":400000000,"eps":-0.4202,"marketStatus":"已收盘","change":-0.13,"latestTime":"12-24 15:00:00","open":8.88,"high":8.94,"low":8.74,"amount":40040200,"amplitude":0.0223,"askPrice":8.82,"askSize":119,"bidPrice":8.81,"bidSize":465,"shortable":0,"etf":0,"ttmEps":-0.4202,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766626200000},"marketStatusCode":5,"adr":0,"adjPreClose":8.95,"symbolType":"stock","openAndCloseTimeList":[[1766539800000,1766547000000],[1766552400000,1766559600000]],"highLimit":9.4,"lowLimit":8.5,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":400108752,"isCdr":false,"pbRate":5.12,"roa":"--","roe":"--","epsLYR":-0.69,"committee":0.159687,"marketValue":3529000000,"turnoverRate":0.0113,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2025-12-29。","floatMarketCap":3529000000},"requestUrl":"/m/hq/s/605199","defaultTab":"news","newsList":[{"id":"2593654108","title":"异动快报:ST葫芦娃(605199)12月22日10点54分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2593654108","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593654108?lang=zh_cn&edition=full","pubTime":"2025-12-22 11:24","pubTimestamp":1766373857,"startTime":"0","endTime":"0","summary":"证券之星12月22日盘中消息,10点54分ST葫芦娃触及涨停板。其所属行业中药目前上涨。领涨股为*ST长药。该股为海南概念,幽门螺杆菌概念,化学原料药概念热股,当日海南概念概念上涨9.58%,幽门螺杆菌概念概念上涨0.7%,化学原料药概念上涨0.38%。12月19日的资金流向数据方面,主力资金净流入722.59万元,占总成交额16.18%,游资资金净流出198.39万元,占总成交额4.44%,散户资金净流出524.2万元,占总成交额11.74%。","market":"fut","thumbnail":" http://caiji.3g.cnfol.com/colect/202512/22/20251222147611.png","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202512/22/20251222147611.png"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20251222/31880537.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","605199"],"gpt_icon":0},{"id":"2591647377","title":"ST葫芦娃(605199)披露召开2025年第三次临时股东大会通知,12月15日股价下跌1.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2591647377","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2591647377?lang=zh_cn&edition=full","pubTime":"2025-12-15 22:39","pubTimestamp":1765809591,"startTime":"0","endTime":"0","summary":"截至2025年12月15日收盘,ST葫芦娃报收于8.62元,较前一交易日下跌1.6%,最新总市值为34.49亿元。该股当日开盘8.69元,最高8.69元,最低8.58元,成交额达2580.88万元,换手率为0.75%。近日,海南葫芦娃药业集团股份有限公司发布公告,宣布将于2025年12月31日召开2025年第三次临时股东大会,会议采取现场投票与网络投票相结合的方式。会议登记时间为12月25日,可通过现场或邮件方式登记。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121500036390.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605199"],"gpt_icon":0},{"id":"2589339569","title":"ST葫芦娃(605199)披露控股股东部分股份被司法冻结,12月08日股价下跌0.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2589339569","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589339569?lang=zh_cn&edition=full","pubTime":"2025-12-08 17:52","pubTimestamp":1765187572,"startTime":"0","endTime":"0","summary":"截至2025年12月8日收盘,ST葫芦娃报收于8.88元,较前一交易日下跌0.45%,最新总市值为35.53亿元。近日,海南葫芦娃药业集团股份有限公司发布关于控股股东部分股份被司法冻结的公告。公告显示,公司控股股东海南葫芦娃投资发展有限公司持有公司167,079,000股,占总股本41.76%。冻结期限自2025年12月5日至2028年12月3日,冻结申请人为海口市中级人民法院。此次冻结系因葫芦娃投资质押给山东省国际信托股份有限公司的股份触发提前赎回条款所致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120800022659.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605199"],"gpt_icon":0},{"id":"2588257627","title":"ST葫芦娃(605199)披露公司股票被实施其他风险警示相关事项的进展公告,12月01日股价下跌0.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588257627","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588257627?lang=zh_cn&edition=full","pubTime":"2025-12-01 17:55","pubTimestamp":1764582939,"startTime":"0","endTime":"0","summary":"截至2025年12月1日收盘,ST葫芦娃报收于9.26元,较前一交易日下跌0.86%,最新总市值为37.05亿元。该股当日开盘9.32元,最高9.36元,最低9.24元,成交额达2949.28万元,换手率为0.79%。近日,海南葫芦娃药业集团股份有限公司发布关于公司股票被实施其他风险警示相关事项的进展公告。公告显示,公司因2024年度内部控制被出具否定意见审计报告,股票自2025年4月30日起被实施其他风险警示。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120100023730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605199","BK0239"],"gpt_icon":0},{"id":"2585192351","title":"异动快报:ST葫芦娃(605199)11月21日14点54分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2585192351","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585192351?lang=zh_cn&edition=full","pubTime":"2025-11-21 14:55","pubTimestamp":1763708124,"startTime":"0","endTime":"0","summary":"证券之星11月21日盘中消息,14点54分ST葫芦娃(605199)触及跌停板。目前价格9.22,下跌4.55%。其所属行业中药目前下跌。领涨股为众生药业。该股为中药,优化生育(三孩),海南概念概念热股。11月20日的资金流向数据方面,主力资金净流出420.25万元,占总成交额6.63%,游资资金净流入275.79万元,占总成交额4.35%,散户资金净流入144.46万元,占总成交额2.28%。近5日资金流向一览见下表:ST葫芦娃主要指标及行业内排名如下:以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112100017158.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605199"],"gpt_icon":0},{"id":"2581545790","title":"异动快报:ST葫芦娃(605199)11月5日9点49分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2581545790","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581545790?lang=zh_cn&edition=full","pubTime":"2025-11-05 09:50","pubTimestamp":1762307437,"startTime":"0","endTime":"0","summary":"证券之星11月5日盘中消息,9点49分ST葫芦娃触及涨停板。目前价格9.83,上涨4.35%。其所属行业中药目前下跌。领涨股为众生药业。该股为海南概念,幽门螺杆菌概念,优化生育(三孩)概念热股,当日海南概念概念上涨3.36%,幽门螺杆菌概念概念上涨0.61%,优化生育(三孩)概念上涨0.58%。11月4日的资金流向数据方面,主力资金净流出259.16万元,占总成交额4.96%,游资资金净流入478.61万元,占总成交额9.17%,散户资金净流出219.45万元,占总成交额4.2%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500008106.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605199"],"gpt_icon":0},{"id":"2580472953","title":"每周股票复盘:ST葫芦娃(605199)股东户数降13.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580472953","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580472953?lang=zh_cn&edition=full","pubTime":"2025-11-02 06:43","pubTimestamp":1762036990,"startTime":"0","endTime":"0","summary":"截至2025年10月31日收盘,ST葫芦娃报收于9.2元,较上周的9.03元上涨1.88%。本周,ST葫芦娃10月29日盘中最高价报9.28元。ST葫芦娃当前最新总市值36.81亿元,在中药板块市值排名49/67,在两市A股市值排名4100/5163。股本股东变化截至2025年9月30日,ST葫芦娃股东户数为2.73万户,较6月30日减少4293户,减幅13.59%。业绩披露要点ST葫芦娃2025年三季报显示,前三季度主营收入6.83亿元,同比下降33.88%;归母净利润-1121.39万元,同比上升90.46%;扣非净利润-4583.18万元,同比上升71.29%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110200001395.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605199"],"gpt_icon":0},{"id":"2579451375","title":"ST葫芦娃(605199)9月30日股东户数2.73万户,较上期减少13.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579451375","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579451375?lang=zh_cn&edition=full","pubTime":"2025-10-31 17:32","pubTimestamp":1761903130,"startTime":"0","endTime":"0","summary":"证券之星消息,近日ST葫芦娃披露,截至2025年9月30日公司股东户数为2.73万户,较6月30日减少4293.0户,减幅为13.59%。在中药行业个股中,ST葫芦娃股东户数低于行业平均水平,截至9月30日,中药行业平均股东户数为5.36万户。从股价来看,2025年6月30日至2025年9月30日,ST葫芦娃区间跌幅为2.65%,在此期间股东户数减少4293.0户,减幅为13.59%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100036699.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605199","BK0239"],"gpt_icon":0},{"id":"2579514132","title":"ST葫芦娃第三季度亏损1362万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2579514132","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579514132?lang=zh_cn&edition=full","pubTime":"2025-10-30 19:53","pubTimestamp":1761825180,"startTime":"0","endTime":"0","summary":" 其中第三季度,公司营业收入为1.75亿元,同比下降49.6%;归母净利润亏损1362万元,同比下降365.4%;扣非归母净利润自去年同期亏损42万元变为亏损2705万元,亏损额进一步扩大;EPS为-0.0341元。 截至三季度末,公司总资产28.0亿元,较上年度末下降5.6%;归母净资产为6.89亿元,较上年度末下降1.6%。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-10-30/doc-infvsqmm9456258.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["605199","BK0239"],"gpt_icon":0},{"id":"2578615320","title":"ST葫芦娃最新公告:中药创新药小儿胆青双解颗粒获药物临床试验批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2578615320","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578615320?lang=zh_cn&edition=full","pubTime":"2025-10-27 16:53","pubTimestamp":1761555221,"startTime":"0","endTime":"0","summary":"ST葫芦娃(605199.SH)公告称,公司近日收到国家药品监督管理局核准签发的关于小儿胆青双解颗粒的《药物临床试验批准通知书》,同意本品开展临床试验。该药品属于中药创新药1.1类,核心功效为清热透表、泻火解毒、表里双解,用于儿童流行性感冒表里俱热证。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700022007.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605199","BK1574","159992","BK1161","BK0239","06978"],"gpt_icon":0},{"id":"2576115049","title":"每周股票复盘:ST葫芦娃(605199)葫芦娃拟投1125万与关联方合作研发新药","url":"https://stock-news.laohu8.com/highlight/detail?id=2576115049","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576115049?lang=zh_cn&edition=full","pubTime":"2025-10-19 03:40","pubTimestamp":1760816421,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘,ST葫芦娃报收于8.96元,较上周的8.88元上涨0.9%。本周,ST葫芦娃10月17日盘中最高价报9.13元。本周关注点公司公告汇总:葫芦娃拟与关联方签署技术合作开发合同,总金额1,125万元。公司公告汇总海南葫芦娃药业集团股份有限公司于2025年10月15日召开职工代表大会,选举王清涛先生为第四届董事会职工代表董事。项目完成后,葫芦娃分别持有50%和40%权益。交易已获董事会及独立董事审议通过,无需提交股东大会审议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101900000743.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605199"],"gpt_icon":0},{"id":"2576361051","title":"ST葫芦娃(605199)披露取消监事会并修订公司章程议案获通过,10月17日股价上涨1.93%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576361051","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576361051?lang=zh_cn&edition=full","pubTime":"2025-10-17 22:36","pubTimestamp":1760711773,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘,ST葫芦娃报收于8.96元,较前一交易日上涨1.93%,最新总市值为35.85亿元。公告显示,本次会议由董事会召集,于2025年10月17日以现场和网络投票方式召开,出席会议股东共233人,代表股份303,558,250股,占公司有表决权股份总数的75.8689%。会议审议通过《关于取消监事会并修订〈公司章程〉及其附件的议案》等八项议案。其中第一项议案获三分之二以上有效表决权通过,其余议案获过半数通过。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101700038621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605199","BK0239"],"gpt_icon":0},{"id":"2576554300","title":"ST葫芦娃最新公告:拟与关联方签署技术合作开发合同","url":"https://stock-news.laohu8.com/highlight/detail?id=2576554300","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576554300?lang=zh_cn&edition=full","pubTime":"2025-10-17 21:39","pubTimestamp":1760708395,"startTime":"0","endTime":"0","summary":"ST葫芦娃(605199.SH)公告称,公司拟与关联方杭州康领先医药科技有限公司签署两个项目的《技术合作开发合同》,共同开发“昂丹司琼口溶膜”、“依达拉奉右莰醇注射用浓溶液”项目,合同金额预估分别为910万元和215万元,共计1125万元。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101700037145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605199"],"gpt_icon":0},{"id":"2575473699","title":"ST葫芦娃(605199)披露选举第四届董事会职工代表董事,10月15日股价上涨0.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575473699","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575473699?lang=zh_cn&edition=full","pubTime":"2025-10-15 22:42","pubTimestamp":1760539334,"startTime":"0","endTime":"0","summary":"截至2025年10月15日收盘,ST葫芦娃报收于8.81元,较前一交易日上涨0.57%,最新总市值为35.25亿元。公告称,公司于2025年10月15日召开职工代表大会,选举王清涛先生为公司第四届董事会职工代表董事。王清涛先生将与公司2025年第二次临时股东大会选举产生的3名非独立董事及3名独立董事共同组成第四届董事会,任期一致。董事会成员共7名,其中兼任高级管理人员及职工代表董事人数未超过董事总数的二分之一,符合相关法规要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101500038476.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605199"],"gpt_icon":0},{"id":"2575471639","title":"ST葫芦娃(605199)披露拟取消监事会并改由董事会审计委员会行使监事会职权,10月13日股价下跌1.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575471639","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575471639?lang=zh_cn&edition=full","pubTime":"2025-10-13 17:26","pubTimestamp":1760347582,"startTime":"0","endTime":"0","summary":"截至2025年10月13日收盘,ST葫芦娃报收于8.76元,较前一交易日下跌1.35%,最新总市值为35.05亿元。近日,海南葫芦娃药业集团股份有限公司发布2025年第二次临时股东大会会议资料,宣布将于2025年10月17日召开第二次临时股东大会,审议多项重要议案。其中最受关注的事项为拟取消公司监事会,由董事会审计委员会行使监事会职权,并相应修订《公司章程》及相关议事规则。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101300020156.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605199"],"gpt_icon":0},{"id":"2574682344","title":"每周股票复盘:ST葫芦娃(605199)拟取消监事会并改组董事会","url":"https://stock-news.laohu8.com/highlight/detail?id=2574682344","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574682344?lang=zh_cn&edition=full","pubTime":"2025-10-12 03:30","pubTimestamp":1760211032,"startTime":"0","endTime":"0","summary":"截至2025年10月10日收盘,ST葫芦娃报收于8.88元,较上周的8.83元上涨0.57%。本周,ST葫芦娃10月10日盘中最高价报8.95元。ST葫芦娃当前最新总市值35.53亿元,在中药板块市值排名50/67,在两市A股市值排名4139/5158。上述议案已由第三届董事会2025年第五次临时会议审议通过,相关文件已于2025年9月30日在上海证券交易所网站披露。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101200000910.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605199","BK0239"],"gpt_icon":0},{"id":"2571389937","title":"ST葫芦娃(605199)披露为全资子公司提供担保公告,9月29日股价下跌0.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2571389937","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571389937?lang=zh_cn&edition=full","pubTime":"2025-09-29 17:45","pubTimestamp":1759139140,"startTime":"0","endTime":"0","summary":"近日,海南葫芦娃药业集团股份有限公司发布公告称,公司为全资子公司广西维威制药有限公司向兴业银行南宁分行申请贷款提供连带责任保证担保,担保金额3,850万元,担保期间为主合同债务履行期限届满之日起三年,担保范围包括债权本金及相关利息、违约金、实现债权的费用等,无反担保。广西维威为公司持股100%的全资子公司,法定代表人为韦天宝,注册资本18,000万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092900024613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["605199","BK0239"],"gpt_icon":0},{"id":"2567118635","title":"ST葫芦娃最新公告:收到小儿肺热咳喘颗粒临床试验批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2567118635","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567118635?lang=zh_cn&edition=full","pubTime":"2025-09-15 18:00","pubTimestamp":1757930417,"startTime":"0","endTime":"0","summary":"ST葫芦娃(605199.SH)公告称,公司近日收到国家药监局核准签发的关于小儿肺热咳喘颗粒的《药物临床试验批准通知书》,同意本品开展用于儿童流行性感冒的临床试验。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091500023641.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605199"],"gpt_icon":0},{"id":"2567190751","title":"ST葫芦娃最新公告:公司及全资子公司获得磷酸奥司他韦干混悬剂和乳果糖口服溶液药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2567190751","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567190751?lang=zh_cn&edition=full","pubTime":"2025-09-15 17:50","pubTimestamp":1757929809,"startTime":"0","endTime":"0","summary":"ST葫芦娃(605199.SH)公告称,公司及全资子公司广西维威近日分别收到国家药监局核准签发的磷酸奥司他韦干混悬剂、乳果糖口服溶液的《药品注册证书》。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091500023352.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","605199"],"gpt_icon":0},{"id":"2565555992","title":"ST葫芦娃:获头孢地尼胶囊药品注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2565555992","media":"同花顺财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565555992?lang=zh_cn&edition=full","pubTime":"2025-09-05 16:52","pubTimestamp":1757062334,"startTime":"0","endTime":"0","summary":"ST葫芦娃公告,近日收到国家药品监督管理局核准签发的关于头孢地尼胶囊的《药品注册证书》。该药品适用于对头孢地尼敏感的多种细菌所引起的感染,包括咽喉炎、扁桃体炎、肺炎、中耳炎等。截至目前,公司对该产品已累计投入研发费用449.57万元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/09/05165252950731.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","605199"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766616032743,"stockEarnings":[{"period":"1week","weight":0.0316},{"period":"1month","weight":-0.0434},{"period":"3month","weight":0.0057},{"period":"6month","weight":-0.0276},{"period":"1year","weight":-0.4562},{"period":"ytd","weight":-0.4463}],"compareEarnings":[{"period":"1week","weight":0.0183},{"period":"1month","weight":0.0272},{"period":"3month","weight":0.0227},{"period":"6month","weight":0.1509},{"period":"1year","weight":0.1613},{"period":"ytd","weight":0.1758}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"海南葫芦娃药业集团股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"27294人(较上一季度减少13.59%)","perCapita":"14659股","listingDate":"2020-07-10","address":"海南省海口市秀英区海口国家高新区药谷工业园二期药谷四路8号","registeredCapital":"40010万元","survey":" 海南葫芦娃药业集团股份有限公司的主营业务是药品研发、生产、销售。公司的主要产品是小儿肺热咳喘颗粒、肠炎宁胶囊、肠炎宁颗粒、复方鲜石斛颗粒、克咳片、复方赖氨酸颗粒、复方感冒灵颗粒、养阴清肺膏、缬沙坦氨氯地平片(I)、磷酸奥司他韦胶囊、布洛芬混悬液。公司小儿肺热咳喘颗粒(每袋4克装)、肠炎宁胶囊(每粒装0.3g)、肠炎宁颗粒(每袋2g装)为独家规格产品。小儿肺热咳喘颗粒(4g)荣获西鼎会“2023-2024年度中国药品零售市场潜力品牌”、米思会“2024中国医药·品牌榜”、2024大健康产业“产品引领奖”等荣誉。公司产品肠炎宁颗粒荣获星辰会“零售药店最受欢迎的明星单品”、“2024年度中国非处方药产品综合统计排名第二名”、米思会“2024中国医药·品牌榜”、西普会“2024健康产业品牌榜”西普金奖等荣誉。复方赖氨酸颗粒荣获“2023-2024年家庭常备药儿科用药品牌”称号。","listedPrice":5.19},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ST葫芦娃(605199)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ST葫芦娃(605199)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ST葫芦娃,605199,ST葫芦娃股票,ST葫芦娃股票老虎,ST葫芦娃股票老虎国际,ST葫芦娃行情,ST葫芦娃股票行情,ST葫芦娃股价,ST葫芦娃股市,ST葫芦娃股票价格,ST葫芦娃股票交易,ST葫芦娃股票购买,ST葫芦娃股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ST葫芦娃(605199)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ST葫芦娃(605199)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}